SequelSEC

Strata Critical Medical, Inc. SRTA

Services-Health Services · CIK 0001779128 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$255.98M
Fiscal year ended 2026-06-30
Operating income
-$20.41M
Fiscal year ended 2026-06-30
Free cash flow
-$48.45M
Fiscal year ended 2026-06-30

Strata Critical Medical, Inc. (SRTA) reported revenue of $255.98M and net income of $40.22M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Strata Critical Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.

Income

Strata Critical Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$255.98M
Cost of revenue$203.36M
Gross profit$52.62M
Operating income-$20.41M
Net income$40.22M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$23.16M
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Strata Critical Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$16.32M
Total assets$332.70M
Current assets$121.01M
Total liabilities$53.38M
Current liabilities$45.78M
Total equity incl. NCI$279.32M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$43.41M
Goodwill$106.95M
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

Strata Critical Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$36.03M
Capital expenditures$12.42M
Investing cash flow$1.51M
Financing cash flow-$8.60M
Net change in cash-$43.74M
Stock-based compensation$17.01M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$16.29M

Derived

Strata Critical Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$48.45M
Gross margin20.6%
Operating margin-8.0%
FCF margin-18.9%
SBC / revenue6.6%
Current ratio2.64x
Revenue YoY growth66.8%
Net margin15.7%
R&D / revenueUnavailable
CapEx / revenue4.9%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SRTA in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-04View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-03View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

ATPC DCGO INNV LDDD LFST NPLY OMDA PIII PNTG PRVA USPH VSEE

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.